Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06561828 · ClinicalTrials.gov registry record · Early Phase 1
Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making
A Early Phase 1 study of Normal Physiology, sponsored by National Institute on Drug Abuse (NIDA).
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT06561828: Recruiting Early Phase 1 study of Normal Physiology, sponsored by National Institute on Drug Abuse (NIDA).
NCT06561828 is a Early Phase 1 study of Normal Physiology that is actively recruiting participants, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 600 participants, below the 1,269-participant average among 25 other Normal Physiology trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06561828, a Early Phase 1 study of Normal Physiology, is actively recruiting participants, sponsored by National Institute on Drug Abuse (NIDA).
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: People with substance use disorder (SUD) often have changes in brain function that can make it difficult to control drug-seeking behavior. These changes may heighten the urge to use drugs or lessen the desire to seek nondrug-related rewards. Researchers want to know how a technique called transcranial magnetic stimulation (TMS) may cause changes in brain activity that may help people with SUD. Objective: To test TMS in healthy volunteers. Eligibility: Healthy people aged 18 to 45 years who are right-handed. Design: Participants can volunteer for up to 5 different experiments. Each experiment requires 2 to 8 clinic visits. Each visit will last 3 to 7 hours. Some visits will include TMS. A coil will be placed on the participant s head. A brief electrical current will pass through the coil to create a magnetic field. Participants may feel a tapping or pulling sensation on the skin under the coil. They may feel a twitch in their face, neck, arm, or leg muscles. Participants may be asked to tense certain muscles during TMS. Some visits will include functional magnetic resonance imaging (fMRI) scans. Participants will lie on a bed that slides into a large tube. They will perform tasks on a computer inside the tube. The fMRI will show which parts of the brain are used during each task. Participants will perform tasks on a computer. Some tasks may be done at a desk as well as during TMS and fMRI. Participants may look at images, listen to sounds, smell odors, or taste flavored liquids. Their vital signs may be monitored and their eye movements may be tracked during tasks.
Primary Outcome
Responses on behavioral tasks
Conditions Studied
Interventions
- DEVICE continuous Theta Burst Stimulation (cTBS)
- DEVICE intermittent Theta Burst Stimulation (iTBS)
- DEVICE sham Theta Burst Stimulation (sham TBS)
Study Locations (1)
Maryland
- National Institute on Drug Abuse - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2026-03-26 |
| Est. Completion | 2044-11-02 |
| Phase | Early Phase 1 |
What NCT06561828 shows while recruiting
NCT06561828 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,269-participant average among 25 other Normal Physiology trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Normal Physiology appearing as the primary indexed condition, and to 3 interventions - of which continuous Theta Burst Stimulation (cTBS) is the first listed.
NCT06561828 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06561828 about?
NCT06561828 is a clinical study titled "Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making". Background: People with substance use disorder (SUD) often have changes in brain function that can make it difficult to control drug-seeking behavior. These changes may heighten the urge to use drugs or lessen the desire to seek nondrug-related rewards. Researchers want to know how a technique call...
What is the current status of trial NCT06561828?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 600 participants. The study started on 2026-03-26. Estimated completion is 2044-11-02.
What conditions does trial NCT06561828 study?
This clinical trial studies the following conditions: Normal Physiology.
What interventions are being tested in trial NCT06561828?
The interventions under investigation include: continuous Theta Burst Stimulation (cTBS) (DEVICE), intermittent Theta Burst Stimulation (iTBS) (DEVICE), sham Theta Burst Stimulation (sham TBS) (DEVICE).
Who is sponsoring clinical trial NCT06561828?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06561828 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Normal Physiology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06561828's enrollment target sits among peer trials
600 9th of 25 higher than 17 of 25 other Normal Physiology trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Normal Physiology trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Investigating the Impact of Obesity on Pubertal Development in Girls
RECRUITING
-
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
RECRUITING · NA
-
Influence of Brain Oscillation-Dependent TMS on Motor Function
RECRUITING
-
Sociocultural & Biobehavioral Influences on Pain Expression and Assessment
RECRUITING · NA
-
Clinical and Scientific Assessment of Pain and Painful Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI